• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Fat Tail Daily

Investment Ideas From the Edge of the Bell Curve

  • Menu
    • Commodities
      • Resources and Mining
      • Copper
      • Gold
      • Iron Ore
      • Lithium
      • Silver
      • Graphite
      • Rare Earths
    • Technology
      • AI
      • Bitcoin
      • Cryptocurrency
      • Energy
      • Financial Technology
      • Bio Technology
    • Market Analysis
      • Latest ASX News
      • Dividend Shares
      • ETFs
      • Stocks and Bonds
    • Macro
      • Australian Economy
      • Central Banks
      • World Markets
    • Small Caps
    • More
      • Investment Guides
      • Premium Research
      • Editors
      • About
      • Contact Us
  • Latest
  • Fat Tail Series
  • About Us
Market Analysis Latest ASX News

Bain Capital to Acquire Estia Health for $838 Million

Like 0

By Charlie Ormond, Monday, 07 August 2023

After five months of pursuit, the board of Estia Health have agreed to the revised offer of $838 million from US private equity firm Bain Capital. The deal, subject to shareholder approval, will see the firm buy Estia for $3.20 per share, a 50% premium from the initial time of the offer.

Aged care home operator Estia Health [ASX:EHE] has finally agreed to the takeover bid from private equity firm Bain Capital for $838 million. The deal, which is subject to shareholder approval, would see Bain take control of one of Australia’s largest aged care providers.

Estia Health operates more than 6500 places in 70 sites across the country. The company has been under pressure in recent years due to rising costs and declining occupancy rates.

However, Bain Capital believes that Estia has a solid underlying business and is well-positioned for growth. Estia Health’s shares were up by 8.98% today as investors and shareholders celebrated the takeover, which began in March when Bain first approached Estia.

Shares of Estia are up by 51.72% in the past 12 months. Most of that growth has been seen after the initial offer was made public.

ASX:EHE stock chart

Source: TradingView

Estia Health agrees to the revised bid by Bain Capital

Estia Health announced today that its board have unanimously endorsed the $838 million offer by Bain Capital to acquire Estia for $3.20 per share.

The acceptance of the deal comes after five months of back and forth between the groups in which Estia rejected previous bids of $3 per share.

The current offer of $3.20 represents a 50% premium from the closing price of $2,14 prior to the private-equity firm’s first proposal.

Under the deal, Estia is also allowed to pay fully franked dividends of up to 12 cents per share, giving shareholders an additional 5 cents per share in benefit from franking credits.

With the board’s endorsement of the deal, a vote by shareholders has been earmarked for November.

Bain Capital has approximately $175 billion in assets under management and is known most recently in Australia for buying bankrupt Virgin Australia for $3.5 billion back in 2020.

Estia Health Chairman Dr Gary Weisse remarked today that he had confidence in the company’s outlook, saying:

‘Bain Capital’s interest in Estia Health is a strong endorsement of our strategy to build a market-leading aged care provider focussed on creating high-quality outcomes for our residents and families and an attractive and supportive environment for our employees.

‘We are pleased that Bain Capital has recognised Estia Health’s value as a leading Australian aged care operator with a strong reputation for person-centred care.

‘The Estia Health board is confident as to the outlook for the business, however, recognises that the scheme allows shareholders to realise certain cash value now at an attractive premium.’

The Estia board said an independent report on the company’s value will be sent to shareholders in the lead-up to the scheme meeting in November. Estia has been listed on the ASX since late 2014.

Outlook for Estia Health

The acquisition of Estia Health is a sign that private equity firms continue to see value in the Australian aged-care sector.

The sector faces several significant challenges after the pandemic — principally a major workforce shortage — but it’s also expected to grow significantly in the coming years.

The Government projects that a 40% increase in aged care homes will be required over the next 10 years at a cost of around $25 billion as the population ages.

Australian agedcare workers

Source: AFR

While the deal is still contingent on agreement by shareholders, they are likely to welcome the deal.

The $3.20 per share offer represents a significant premium to Estia’s share price before Bain Capital’s initial offer.

However, some shareholders may be concerned about the impact of the deal on Estia Health’s long-term future or its impact on aged residents.

Typically, private equity organisations invest where they identify quick wins — either in improved asset values or margins.

In aged care, this can be seen through rapid expansion via acquisition, producing scale benefits and resulting margin improvements.

The aged care sector is also seeing substantial interest from other non-traditional players, such as superannuation funds and property Real Estate Investment Trusts (REITs).

This could lead to further consolidation in the sector as smaller cottage operators are acquired by larger firms. Something that recent studies have shown provides mixed results for patients.

The acquisition of Estia Health is a positive development for the company’s medium-term prospects.

It shows that there is interest in the sector despite headwinds that could lead to improvements in the quality of care that is provided to older Australians. This is if appropriate investment follows rather than simply improving margins for Bain.

Window of opportunity

Before you go, I wanted to show you a recent presentation by our veteran trader, Murray Dawes.

Murray has the experience and patience to know when to pursue great trades.

He has had a 33% average portfolio return since 2018 and is known for waiting for the perfect time to move.

And he’s just spotted an opportunity to pick up bargains he thinks don’t come around too often.

He’s dubbed it ‘Window 24’.

Murray isn’t a fast and loose trader but a meticulous reader of charts and manager of risk.

So, when he thinks there are buying opportunities, it’s worthwhile to listen.

You can check out Murray’s ‘Window 24’ presentation here.

Regards,

Charles Ormond,

For Money Morning

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Charlie Ormond

With more than a decade of fintech experience, including stretches in critical roles at budding start-ups and tech titans like Microsoft, Charles is squarely focused on investment opportunities in emerging sectors. Interestingly, his academic foundation in zoology provides an unexpected edge! He applies his scientific training with his analytical mindset to figure out tomorrow’s winners and losers. While traditional institutions stick with ‘safe’ stocks, Charles goes straight for seismic shifts in crypto and AI. He’s an early adopter of both technologies.

Now he’s on a mission to empower everyday investors. He decodes groundbreaking developments in technology stocks before they grab mainstream attention. So, if you seek an unconventional perspective to help capitalise on what’s next in fintech, look no further.

Charlie’s Premium Subscriptions

Publication logo
Alpha Tech Trader
Publication logo
James Altucher’s Early-Stage Crypto Investor Australia

Latest Articles

  • As Political Dumb-Wits Beat the Drums of War: Keep Commodities Front and Centre
    By James Cooper

    In today’s edition, James Cooper looks at the growing hostilities between Pakistan and India through the lens of the commodity cycle. And why it could matter more than most think.

  • The share market bears have no answer to this…
    By Callum Newman

    I came across a handy bit of info from Wilson Asset Management yesterday. Wilson says that there’s strong demand for Chinese assets despite the recent volatility and trade tensions. Why do we care? There could be profit in this.

  • The method in Trump’s tariff madness
    By Jim Rickards

    Trump is pursuing a twenty-first-century version of what was originally known as the American System. A system that made America great in the first place.

Primary Sidebar

Latest Articles

  • As Political Dumb-Wits Beat the Drums of War: Keep Commodities Front and Centre
  • The share market bears have no answer to this…
  • The method in Trump’s tariff madness
  • The first place to look thanks to the US/China truce
  • The trade war is over. Tax cut chaos is next.

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2025 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988